Filtros de búsqueda

Lista de obras de Anna K. Nowak

A Multimodality Imaging Review of Malignant Pleural Mesothelioma Response Assessment

artículo científico publicado en 2011

A Novel Clinical Prediction Model for Prognosis in Malignant Pleural Mesothelioma Using Decision Tree Analysis

artículo científico publicado en 2016

A Phase II Study of Intermittent Sunitinib Malate as Second-Line Therapy in Progressive Malignant Pleural Mesothelioma

artículo científico publicado en 2012

A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma

artículo científico publicado en 2018

A diagnosis of malignant pleural mesothelioma can be made by effusion cytology: results of a 20 year audit

article

A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma.

artículo científico publicado en 2002

A novel prognostic model for malignant mesothelioma incorporating quantitative FDG-PET imaging with clinical parameters

artículo científico publicado en 2010

A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma.

artículo científico publicado en 2015

A phase II clinical trial of the vascular disrupting agent BNC105P as second line chemotherapy for advanced Malignant Pleural Mesothelioma

artículo científico publicado en 2013

A prospective study of surgical patterns of care for high grade glioma in the current era of multimodality therapy.

artículo científico publicado en 2010

A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in mice

artículo científico publicado en 2017

A systematic review and meta-analysis of utility estimates in melanoma.

artículo científico publicado en 2017

Adjuvant chemotherapy for early colon cancer: what survival benefits make it worthwhile?

artículo científico publicado en 2010

An Oasis in the Hospital

artículo científico publicado en 2014

An international, multicenter phase II trial of bortezomib in patients with hepatocellular carcinoma.

artículo científico publicado en 2010

Asbestos exposure: challenges for Australian clinicians

artículo científico publicado en 2016

Assessing quality of life during chemotherapy for pleural mesothelioma: feasibility, validity, and results of using the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire and Lung Cancer Module

artículo científico publicado en 2004

Audit of patients with mesothelioma treated with pemetrexed in a single institution in Western Australia

artículo científico publicado en 2010

Bilateral murine tumor models for characterizing the response to immune checkpoint blockade

scientific article published on 01 April 2020

Bilateral thoracoscopy, mediastinoscopy and laparoscopy, in addition to CT, MRI and PET imaging, are essential to correctly stage and treat patients with mesothelioma prior to trimodality therapy.

artículo científico publicado en 2009

Body composition and nutritional status in malignant pleural mesothelioma: implications for activity levels and quality of life

artículo científico publicado en 2019

CT, RECIST, and malignant pleural mesothelioma.

artículo científico publicado en 2005

Can bevacizumab prolong survival for glioblastoma patients through multiple lines of therapy?

artículo científico publicado en 2014

Capecitabine Versus Classical Cyclophosphamide, Methotrexate, and Fluorouracil As First-Line Chemotherapy for Advanced Breast Cancer

article

Carers of patients with high-grade glioma report high levels of distress, unmet needs, and psychological morbidity during patient chemoradiotherapy

scientific article published on 15 October 2015

Caring for someone with high-grade glioma: a time of rapid change for caregivers

artículo científico publicado en 2010

Characteristics of TCR Repertoire Associated With Successful Immune Checkpoint Therapy Responses

artículo científico publicado en 2020

Characterization of hypoxia in malignant pleural mesothelioma with FMISO PET-CT.

artículo científico publicado en 2015

Chemoimmunotherapy: an emerging strategy for the treatment of malignant mesothelioma.

scientific article published on 04 May 2009

Chemoimmunotherapy: still waiting for the magic to happen

artículo científico publicado en 2014

Chemotherapy and immunotherapy: mapping the road ahead.

artículo científico

Chemotherapy broadens the range of tumor antigens seen by cytotoxic CD8(+) T cells in vivo.

artículo científico publicado en 2012

Cisplatin and gemcitabine in malignant mesothelioma

artículo científico publicado en 2005

Clinical management and survival outcomes of gliosarcomas in the era of multimodality therapy

artículo científico publicado en 2013

Combination immune checkpoint blockade as an effective therapy for mesothelioma

article

Combined chemoimmunotherapy of solid tumours: improving vaccines?

artículo científico publicado en 2006

Comparison between site and central radiological assessments for patients with recurrent glioblastoma on a clinical trial.

artículo científico publicado en 2017

Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma

artículo científico publicado en 2014

Compliance with reporting guidelines by Australian pathologists: an audit of the quality of histopathology reporting in high-grade glioma

article

Continuing or ceasing bevacizumab beyond progression in recurrent glioblastoma: an exploratory randomized phase II trial

artículo científico publicado en 2017

Contribution of the immune system to the chemotherapeutic response.

artículo científico publicado en 2011

Cosmesis and Breast-Related Quality of Life Outcomes After Intraoperative Radiation Therapy for Early Breast Cancer: A Substudy of the TARGIT-A Trial

artículo científico publicado en 2016

Cosmetic outcome as rated by patients, doctors, nurses and BCCT.core software assessed over 5 years in a subset of patients in the TARGIT-A Trial.

artículo científico publicado en 2018

Current and Future Management of Malignant Mesothelioma : A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer and Mesothelioma Applied Research Foundatio

artículo científico publicado en 2018

Current state and future directions of pleural mesothelioma imaging

artículo científico publicado en 2007

Cyclophosphamide chemotherapy sensitizes tumor cells to TRAIL-dependent CD8 T cell-mediated immune attack resulting in suppression of tumor growth

artículo científico publicado en 2009

Darkroom hepatitis after exposure to hydroquinone

scientific article published in The Lancet

Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies

artículo científico publicado en 2015

Dexamethasone differentially depletes tumour and peripheral blood lymphocytes and can impact the efficacy of chemotherapy/checkpoint blockade combination treatment

scientific article published on 13 July 2019

Diagnosing cancer in the bush: a mixed-methods study of symptom appraisal and help-seeking behaviour in people with cancer from rural Western Australia.

artículo científico publicado en 2013

Dietary vitamin D supplementation does not reduce the incidence or severity of asbestos-induced mesothelioma in a mouse model

artículo científico publicado en 2014

Disease volumes as a marker for patient response in malignant pleural mesothelioma.

artículo científico publicado en 2012

Distress and psychological morbidity do not reduce over time in carers of patients with high-grade glioma

artículo científico publicado en 2016

Do carer's levels of unmet needs change over time when caring for patients diagnosed with high-grade glioma and how are these needs correlated with distress?

artículo científico publicado en 2017

Does CA125 binding to mesothelin impact the detection of malignant mesothelioma?

artículo científico publicado en 2013

Dynamic versus static biomarkers in cancer immune checkpoint blockade: unravelling complexity.

artículo científico publicado en 2017

EURACAN/IASLC Proposals for Updating the Histologic Classification of Pleural Mesothelioma: Towards a More Multidisciplinary Approach

scientific article published on 20 September 2019

Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of serial 18F-FDG PET scans.

artículo científico publicado en 2007

Effect of NSAIDS and COX-2 inhibitors on the incidence and severity of asbestos-induced malignant mesothelioma: evidence from an animal model and a human cohort

artículo científico publicado en 2014

Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial

artículo científico publicado en 2007

Elderly dendritic cells respond to LPS/IFN-γ and CD40L stimulation despite incomplete maturation.

artículo científico publicado en 2018

Enhancing the efficacy of immunotherapy using radiotherapy

artículo científico publicado en 2020

Evaluation of the psychometric properties and minimally important difference of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM)

artículo científico publicado en 2019

Evolving management of low grade glioma: No consensus amongst treating clinicians

artículo científico publicado en 2015

Existing models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma

scientific article published on 27 August 2013

Feasibility Testing and Refinement of a Supportive Educational Intervention for Carers of Patients with High-Grade Glioma - a Pilot Study

artículo científico publicado en 2017

First interim analysis of a randomised trial of whole brain radiotherapy in melanoma brain metastases confirms high data quality.

artículo científico publicado en 2015

Glioblastoma stem-like cells: at the root of tumor recurrence and a therapeutic target.

artículo científico publicado en 2014

Guidelines for the diagnosis and treatment of malignant pleural mesothelioma

artículo científico publicado en 2013

Health-related quality of life outcomes from CABARET: a randomized phase 2 trial of carboplatin and bevacizumab in recurrent glioblastoma.

artículo científico publicado en 2017

Human mesothelioma induces defects in dendritic cell numbers and antigen-processing function which predict survival outcomes

artículo científico publicado en 2015

Ibudilast sensitizes glioblastoma to temozolomide by targeting Macrophage Migration Inhibitory Factor (MIF)

artículo científico publicado en 2019

Imaging in pleural mesothelioma: A review of the 12th International Conference of the International Mesothelioma Interest Group

artículo científico

Imaging in pleural mesothelioma: A review of the 13th International Conference of the International Mesothelioma Interest Group

artículo científico publicado en 2016

Imaging in pleural mesothelioma: a review of imaging research presented at the 9th International Meeting of the International Mesothelioma Interest Group.

scientific article published on 11 June 2010

Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide

artículo científico publicado en 2009

Immune checkpoint inhibition for the treatment of mesothelioma

artículo científico publicado en 2019

Immunological checkpoint inhibitors enter adolescence

artículo científico publicado en 2013

Immunotherapy trials in mesothelioma - promising results, but don't stop here

scientific article published on 01 December 2019

Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells

artículo científico publicado en 2003

Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study

artículo científico publicado en 2017

Intraoperative radiotherapy for early breast cancer: do health professionals choose convenience or risk?

artículo científico publicado en 2014

LUME-Meso: Design and Rationale of the Phase III Part of a Placebo-Controlled Study of Nintedanib and Pemetrexed/Cisplatin Followed by Maintenance Nintedanib in Patients With Unresectable Malignant Pleural Mesothelioma

artículo científico publicado en 2017

Low stromal Foxp3+ regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancer

artículo científico publicado en 2015

Lung cancer clinicians' preferences for adjuvant chemotherapy in non-small-cell lung cancer: what makes it worthwhile?

artículo científico publicado en 2011

Lung volume measurements as a surrogate marker for patient response in malignant pleural mesothelioma.

artículo científico publicado en 2013

Maintenance Defactinib Versus Placebo After First-Line Chemotherapy in Patients With Merlin-Stratified Pleural Mesothelioma: COMMAND-A Double-Blind, Randomized, Phase II Study

artículo científico publicado en 2019

Malignant pleural mesothelioma: an update on diagnosis and treatment options

artículo científico publicado en 2016

Marked functional improvement after combined chemoradiotherapy for cervical spine glioblastoma causing quadriparesis in an adolescent

artículo científico publicado en 2014

Mesothelin-family proteins and diagnosis of mesothelioma

artículo científico publicado en 2003

MexTAg mice exposed to asbestos develop cancer that faithfully replicates key features of the pathogenesis of human mesothelioma

article

Modified RECIST criteria for assessment of response in malignant pleural mesothelioma

artículo científico publicado en 2004

Multigene profiling to identify alternative treatment options for glioblastoma: a pilot study

artículo científico publicado en 2014

Multimodality Imaging Review of Malignant Pleural Mesothelioma Diagnosis and Staging

artículo científico publicado en 2011

Network analysis of immunotherapy-induced regressing tumours identifies novel synergistic drug combinations.

artículo científico publicado en 2015

Nintedanib Plus Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma: Phase II Results From the Randomized, Placebo-Controlled LUME-Meso Trial.

artículo científico publicado en 2017

Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial

scientific article published on 15 May 2019

Novel Targeted Therapies and Vaccination Strategies for Mesothelioma ⬇️

artículo científico publicado el 1 de junio de 2011

Observer variability in mesothelioma tumor thickness measurements: defining minimally measurable lesions.

artículo científico publicado en 2014

Optimization of response classification criteria for patients with malignant pleural mesothelioma.

artículo científico publicado en 2012

Outcome for patients with malignant pleural mesothelioma referred for Trimodality therapy in Western Australia.

scientific article published on August 2009

Overexpression and altered glycosylation of MUC1 in malignant mesothelioma.

artículo científico publicado en 2008

PD-L1 on peripheral blood T lymphocytes is prognostic in patients with non-small cell lung cancer (NSCLC) treated with EGFR inhibitors

artículo científico publicado en 2015

PathoFusion: An Open-Source AI Framework for Recognition of Pathomorphological Features and Mapping of Immunohistochemical Data

artículo científico publicado en 2021

Pathologic Considerations and Standardization in Mesothelioma Clinical Trials

scientific article published on 28 June 2019

Patient and caregiver perceptions of communication of prognosis in high grade glioma

artículo científico publicado en 2010

Patient preferences for adjuvant radiotherapy in early breast cancer are strongly influenced by treatment received through random assignment

scientific article published on 14 January 2019

Pembrolizumab as Palliative Immunotherapy in Malignant Pleural Mesothelioma

artículo científico publicado en 2018

Peripheral CD8+ T cell proliferation is prognostic for patients with advanced thoracic malignancies

article

Phase 2 trial of temozolomide and pegylated liposomal doxorubicin in the treatment of patients with glioblastoma multiforme following concurrent radiotherapy and chemotherapy

artículo científico publicado en 2011

Phase II trials in mesothelioma: An increasing challenge

artículo científico publicado en 2005

Prediction modelling using routine clinical parameters to stratify survival in Malignant Pleural Mesothelioma patients undergoing cytoreductive surgery

artículo científico publicado en 2018

Predictors of distress and poorer quality of life in High Grade Glioma patients.

artículo científico publicado en 2015

Progress in the Management of Malignant Pleural Mesothelioma in 2017.

artículo científico publicado en 2018

Protocol for the Care-IS Trial: a randomised controlled trial of a supportive educational intervention for carers of patients with high-grade glioma (HGG).

artículo científico publicado en 2015

Radiologic Considerations and Standardization of Malignant Pleural Mesothelioma Imaging Within Clinical Trials: Consensus Statement from the NCI Thoracic Malignancy Steering Committee - International Association for the Study of Lung Cancer - Mesoth

artículo científico publicado en 2019

Radiotherapy in the management of high-grade gliomas diagnosed in Western Australia: a patterns of care study

artículo científico publicado en 2012

Randomized Controlled Trial of Shared Care for Patients With Cancer Involving General Practitioners and Cancer Specialists

artículo científico publicado en 2015

Reply to K. Masuda et al

scientific article published on 22 July 2019

Response to comment on 'Existing prognostic models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma'.

artículo científico publicado en 2014

Restoration of defective cross-presentation in tumors by gemcitabine.

artículo científico publicado en 2015

Revised Modified Response Evaluation Criteria in Solid Tumors for Assessment of Response in Malignant Pleural Mesothelioma (Version 1.1)

artículo científico publicado en 2018

Sensitization to immune checkpoint blockade through activation of a STAT1/NK axis in the tumor microenvironment

scientific article published on 01 July 2019

Serial immunomonitoring of cancer patients receiving combined antagonistic anti-CD40 and chemotherapy reveals consistent and cyclical modulation of T cell and dendritic cell parameters.

artículo científico publicado en 2017

Serum soluble mesothelin concentrations in malignant pleural mesothelioma: relationship to tumor volume, clinical stage and changes in tumor burden.

artículo científico publicado en 2010

Small cell lung cancer presenting with paraneoplastic limbic encephalitis

artículo científico publicado en 2011

Soluble mesothelin-related protein--a blood test for mesothelioma

artículo científico publicado en 2005

Somatic mutations in glioblastoma are associated with methylguanine-DNA methyltransferase methylation.

artículo científico publicado en 2015

Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide.

artículo científico publicado en 2006

Statins do not alter the incidence of mesothelioma in asbestos exposed mice or humans

artículo científico publicado en 2014

Strong spontaneous tumor neoantigen responses induced by a natural human carcinogen

artículo científico publicado en 2015

Synergistic effect of CTLA-4 blockade and cancer chemotherapy in the induction of anti-tumor immunity

artículo científico publicado en 2013

Systemic therapy for advanced hepatocellular carcinoma: a review.

artículo científico publicado en 2004

Targeting Aggressive Cancer Stem Cells in Glioblastoma

artículo científico publicado en 2015

Targeting angiogenesis for patients with unresectable malignant pleural mesothelioma

scientific article published on 01 April 2019

Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, multicentre, randomised phase 3 study

artículo científico publicado en 2013

The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer

article

The IASLC Mesothelioma Staging Project: Improving Staging of a Rare Disease Through International Participation

artículo científico publicado en 2016

The IASLC Mesothelioma Staging Project: Proposals for Revisions of the N Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma

artículo científico publicado en 2016

The IASLC Mesothelioma Staging Project: Proposals for Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma

artículo científico publicado en 2016

The IASLC Mesothelioma Staging Project: Proposals for the M Descriptors and for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Mesothelioma

artículo científico publicado en 2016

The Improving Rural Cancer Outcomes (IRCO) Trial: a factorial cluster-randomised controlled trial of a complex intervention to reduce time to diagnosis in rural patients with cancer in Western Australia: a study protocol

artículo científico publicado en 2014

The Improving Rural Cancer Outcomes Trial: a cluster-randomised controlled trial of a complex intervention to reduce time to diagnosis in rural cancer patients in Western Australia

artículo científico publicado en 2017

The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the Clinical and Pathologic Staging of Small Cell Lung Cancer in the Forthcoming Eighth Edition of the TNM Classification for Lung C

article

The MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomide

artículo científico publicado en 2015

The antioxidants vitamins A and E and selenium do not reduce the incidence of asbestos-induced disease in a mouse model of mesothelioma.

artículo científico publicado en 2012

The impact of case discussion at a multidisciplinary team meeting on the treatment and survival of patients with inoperable non-small cell lung cancer

artículo científico publicado en 2009

The information and support needs of patients diagnosed with High Grade Glioma

artículo científico publicado en 2009

The median informs the message: accuracy of individualized scenarios for survival time based on oncologists' estimates

artículo científico publicado en 2013

The potential role of exercise in neuro-oncology

artículo científico publicado en 2015

The role of early magnetic resonance imaging in predicting survival on bevacizumab for recurrent glioblastoma: Results from a prospective clinical trial (CABARET).

artículo científico publicado en 2017

Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial.

artículo científico

Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapy

artículo científico publicado en 2008

Tumor-infiltrating dendritic cells exhibit defective cross-presentation of tumor antigens, but is reversed by chemotherapy.

artículo científico publicado en 2014

Tumour associated lymphocytes in the pleural effusions of patients with mesothelioma express high levels of inhibitory receptors

article

Tumour-infiltrating regulatory T cell density before neoadjuvant chemoradiotherapy for rectal cancer does not predict treatment response.

artículo científico publicado en 2017

Use of tamoxifen in advanced-stage hepatocellular carcinoma. A systematic review.

artículo científico publicado en 2005

Vascular targeting of LIGHT normalizes blood vessels in primary brain cancer and induces intratumoural high endothelial venules

artículo científico publicado en 2018

Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: Statistical Analysis Plan

artículo científico publicado en 2019

Whole brain radiotherapy after local treatment of brain metastases in melanoma patients--a randomised phase III trial ⬇️

artículo científico publicado en 2011

Whole genome and biomarker analysis of patients with recurrent glioblastoma on bevacizumab: A subset analysis of the CABARET trial

scientific article published on 30 September 2019

Young adults diagnosed with high grade gliomas: Patterns of care, outcomes, and impact on employment

artículo científico publicado en 2019

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda